# Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adjuvant-atezolizumab-after-adjuvant-chemotherapy-in-resected-stage-ib-iiia-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Enriqueta Felip,Nasser K. Altorki,Caicun Zhou,Tibor Csőszi,Ihor Vynnychenko,Oleksandr Goloborodko,Alexander Luft,А. Л. Акопов,Alex Martínez‐Martí,Hirotsugu Kenmotsu,Yuh‐Min Chen,Antonio Chella,Shunichi Sugawara,David Voong,Fan Wu,Jing Yi,Yu Deng,Mark L. McCleland,Elizabeth Bennett,Barbara J. Gitlitz,Heather A. Wakelee |
| Citations | 1,498 |
| DOI | 10.1016/s0140-6736(21)02098-5 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3199241644 |
| PMID | 34555333 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)
- [Heather A. Wakelee](https://scholariq.org/researchers/heather-a-wakelee/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Paper topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.